National Peroxide Board of Directors
Get the latest insights into the leadership at National Peroxide. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Ness Nusli Wadia | Chairman |
| Ms. Parvathi Menon | Ind. Non-Executive Director |
| Mr. Jaivir Singh | Ind. Non-Executive Director |
| Mr. Rajiv Arora | Director & CEO |
| Dr.(Ms.) Minnie Bodhanwala | Non Exe.Non Ind.Director |
| Mr. Viraf Mehta | Ind. Non-Executive Director |
National Peroxide Share price
NPL
612.8
10.40 (-1.67%)Last updated on 4 Sep, 2025 | 15:40 IST
BUYSELL
Today's High
625.00
Today's Low
603.00
52 Week Low
552.00
52 Week High
1175.00
The current prices are delayed, login to your account for live prices
LoginNational Peroxide FAQs
The board at National Peroxide consists of experienced professionals, including Mr. Ness Nusli Wadia , Ms. Parvathi Menon , and others, overseeing the company’s strategic and corporate governance.
Directors at National Peroxide are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Ness Nusli Wadia is the current chairman at National Peroxide.
Executive directors at National Peroxide are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, National Peroxide adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At National Peroxide, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.